Georges I Kaddissi MD
Adult Congenital Heart Disease, Interventional Cardiology, Peripheral Endovascular Interventional Cardiology
Physician
Join to View Full Profile
210 W Atlantic AveHaddon Heights, NJ 08035
Phone+1 856-547-0539
Fax+1 856-547-3178
Dr. Kaddissi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Georges Kaddissi is a cardiologist based in Haddon Heights, NJ, with subspecialties in adult congenital heart disease, interventional cardiology, and peripheral endovascular interventional cardiology. He completed his medical education at St Joseph's University Medical School and pursued residency and fellowships at Cooper Medical School of Rowan University/Cooper University Hospital, focusing on cardiovascular and interventional cardiology. Dr. Kaddissi has expertise in general cardiology, including sarcoidosis-related cardiomyopathy, aortic stenosis, and cardiac catheterization procedures. He has contributed to several publications, primarily focusing on transcatheter mitral valve replacement, with one study being significantly cited. He has participated in clinical trials and received accolades such as a Meaningful Use Stage 1 Certification and is recognized as a Fellow of the American College of Cardiology.
Education & Training
Cooper Medical School of Rowan University/Cooper University HospitalFellowship, Interventional Cardiology, 2003 - 2004- Cooper Medical School of Rowan University/Cooper University HospitalFellowship, Cardiovascular Disease, 2000 - 2003
- Cooper Medical School of Rowan University/Cooper University HospitalResidency, Internal Medicine, 1997 - 2000
St Joseph's University Medical SchoolClass of 1996
Certifications & Licensure
NJ State Medical License 2000 - 2027
PA State Medical License 1998 - 2026
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACC) American College of Cardiology
Clinical Trials
- PerQseal® Clinical Study Start of enrollment: 2023 Mar 30
Roles: Contact
Publications & Presentations
PubMed
- 1 citationsEarly U.S. Commercial Experience With a Novel Transcatheter Edge-to-Edge Repair System: Insights From Real-World Data.Thomas Waggoner, Santiago Garcia, Tarun Chakravarty, Moody Makar, Azeem Latib
JACC. Cardiovascular Interventions. 2025-08-25 - 13 citationsPredictors of Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement in Severe Mitral Annular Calcification: An Analysis of the Transc...Abdallah El Sabbagh, Mohammed Al-Hijji, Dee Dee Wang, Mackram F. Eleid, Marina Urena
Circulation. Cardiovascular Interventions. 2021-10-01 - 1 citationsA Pilot Study Comparing Aortic Valve Area Estimates Derived from Fick Cardiac Output with Estimates Based on Cheetah-NICOM Cardiac Output.Ludmil Mitrev, Noud van Helmond, Georges Kaddissi, Ahmed Awad, Kinjal M. Patel
Scientific Reports. 2020-05-12
Authored Content
- 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
- 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
- 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
Press Mentions
Cardiac Partners at Cooper, Inspira Are 1st in Region to Reach Heart Valve Device MilestoneMarch 24th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
